Natera [NTRA] vs Thermo Fisher [TMO] Detailed Stock Comparison

Natera Inc.

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Natera Inc. wins in 2 metrics, Thermo Fisher Scientific Inc. wins in 15 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Natera Inc. Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) N/A 25.84 N/A
Price-to-Book Ratio 15.75 3.31 Thermo Fisher Scientific Inc.
Debt-to-Equity Ratio 12.52 82.91 Natera Inc.
PEG Ratio -272.56 2.29 Thermo Fisher Scientific Inc.
EV/EBITDA -97.62 19.02 Thermo Fisher Scientific Inc.
Profit Margin (TTM) -9.03% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) -3.42% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) N/A 17.89% N/A
Return on Equity -14.32% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) -9.54% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $76.11M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 28.26% 16.53% Natera Inc.
Price-to-Sales Ratio (TTM) 11.86 3.86 Thermo Fisher Scientific Inc.
Enterprise Value $26.50B $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 11.49 4.75 Thermo Fisher Scientific Inc.
Gross Profit Margin (TTM) 66.93% N/A N/A
Revenue per Share (TTM) $17 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $-1.52 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 1.68 0.97 Thermo Fisher Scientific Inc.
Short % of Float 2.43% 1.22% Thermo Fisher Scientific Inc.

Natera Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

NTRA
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Natera Inc.0.51%-1.50%3.85%11.43%-8.57%-7.33%
Thermo Fisher Scientific Inc.0.93%0.87%8.07%0.79%-17.74%-20.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Natera Inc.28.26%322.03%106.13%1,750.52%1,078.17%1,078.17%
Thermo Fisher Scientific Inc.16.53%-12.65%-2.72%220.94%654.32%1,231.84%

Performance & Financial Health Analysis: Natera Inc. vs Thermo Fisher Scientific Inc.

MetricNTRATMO
Market Information
Market Cap i$27.36B$174.55B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,322,4702,356,220
90 Day Avg. Volume i1,333,9932,071,517
Last Close$171.86$473.72
52 Week Range$92.14 - $183.00$385.46 - $643.99
% from 52W High-6.09%-26.44%
All-Time High$183.00 (Jan 13, 2025)$672.34 (Dec 27, 2021)
% from All-Time High-6.09%-29.54%
Growth Metrics
Quarterly Revenue Growth0.40%0.06%
Quarterly Earnings GrowthN/A0.10%
Financial Health
Profit Margin (TTM) i-0.09%0.15%
Operating Margin (TTM) i-0.03%0.18%
Return on Equity (TTM) i-0.14%0.14%
Debt to Equity (MRQ) i12.5282.91
Cash & Liquidity
Book Value per Share (MRQ)$12.26$141.96
Cash per Share (MRQ)$7.59$8.75
Operating Cash Flow (TTM) i$215.30M$8.29B
Levered Free Cash Flow (TTM) i$141.02M$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: Natera Inc. vs Thermo Fisher Scientific Inc.

MetricNTRA (Apr 13, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A25.84
Forward P/E i-272.5617.16
PEG Ratio i-272.562.29
Price to Sales (TTM) i11.863.86
Price to Book (MRQ) i15.753.31
Market Capitalization
Market Capitalization i$27.36B$174.55B
Enterprise Value i$26.50B$214.76B
Enterprise Value Metrics
Enterprise to Revenue i11.494.75
Enterprise to EBITDA i-97.6219.02
Risk & Other Metrics
Beta i1.680.97
Book Value per Share (MRQ) i$12.26$141.96

Financial Statements Comparison: Natera Inc. vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNTRA (2025)TMO (2025)
Revenue/Sales i2.31B44.56B
Cost of Goods Sold i812.93M26.32B
COGS % of Revenue i35.3%59.1%
Gross Profit i1.49B18.24B
Gross Margin i64.7%40.9%
Research & Development i624.11M1.40B
Operating Income (EBIT) i-309.91M8.11B
Operating Margin i-13.4%18.2%
EBITDA i-220.54M11.86B
EBITDA Margin i-9.6%26.6%
Pre-Tax Income i-268.09M7.31B
Pre-Tax Income % of Revenue i-11.6%16.4%
Income Tax i-59.93M547.00M
Income Tax % of Revenue i-2.6%1.2%
Net Income (Profit) i-208.16M6.72B
Profit Margin i-9.0%15.1%

Balance Sheet & Liquidity Metrics

MetricNTRA (2025)TMO (2025)
Cash & Equivalents i1.08B9.85B
Total Current Assets i1.50B28.71B
Total Current Assets % of Revenue i64.9%64.4%
Total Current Liabilities i441.23M15.19B
Total Current Liabilities % of Revenue i19.1%34.1%
Long-Term Debt i118.47M35.85B
Long-Term Debt % of Revenue i5.1%80.5%
Total Shareholders Equity i1.71B53.54B
Retained Earnings i-2.78B59.16B
Retained Earnings % of Revenue i-120.4%132.8%
Property, Plant & Equipment i108.54M0

Cash Flow Statement Comparison

MetricNTRA (2025)TMO (2025)
Operating Cash Flow i135.51M7.82B
Operating Cash Flow % of Revenue i5.9%17.5%
Capital Expenditures i-106.19M-1.48B
Free Cash Flow i76.11M6.29B
FCF Margin i3.3%14.1%
Debt Repayment i0-3.51B
Common Stock Repurchase iN/A-3.00B

Short Interest & Institutional Ownership Analysis

MetricNTRATMO
Shares Short i3.31M4.54M
Short Ratio i2.762.38
Short % of Float i2.43%1.22%
Shares Outstanding i139.69M371.62M
Float Shares i137.44M371.07M
% Held by Insiders i3.07%0.17%
% Held by Institutions i94.58%95.23%
% Held by Public i2.35%4.60%

Dividend Analysis & Yield Comparison: Natera Inc. vs Thermo Fisher Scientific Inc.

MetricNTRATMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026